Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magne Børset

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 17, 2003
[A new nail to the coffin of the medical profession's academic affiliation]Magne Børset
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 16, 2019
Tumour-agnostic drugs and future cancer treatmentMagne Børset
Cancer Letters|December 8, 2020
Protein tyrosine phosphatases in multiple myelomaPegah Abdollahi, Maja Köhn, Magne Børset
Current Opinion in Clinical Nutrition and Metabolic Care|November 2, 2021
Phosphatases of regenerating liver are key regulators of metabolism in cancer cells - role of Serine/Glycine metabolismPegah Abdollahi, Esten N Vandsemb, Magne Børset
Blood Reviews|December 8, 2019
Why do myeloma patients have bone disease? A historical perspectiveMagne Børset, Anders Sundan, Anders Waage, et al.
The American Journal of Case Reports|February 17, 2018
Raised Serum Levels of Syndecan-1 (CD138), in a Case of Acute Idiopathic Systemic Capillary Leak Syndrome (SCLS) (Clarkson's Disease)Ole Wilhelm Bøe, Kjell Sveen, Magne Børset, et al.
The Journal of Biological Chemistry|February 5, 2003
Heparan sulfate regulates targeting of syndecan-1 to a functional domain on the cell surfaceYang Yang, Magne Børset, J Kevin Langford, et al.
Medical Oncology (Northwood, London, England)|February 17, 2007
Bone disease in multiple myelomaØyvind Hjertner, Therese Standal, Magne Børset, et al.
Mediators of Inflammation|June 3, 2014
Bronchoalveolar lavage fluid IFN-γ+ Th17 cells and regulatory T cells in pulmonary sarcoidosisAnders Tøndell, Torolf Moen, Magne Børset, et al.
Translational Oncology|November 17, 2019
Ectonucleotidase CD39 and Checkpoint Signalling Receptor Programmed Death 1 are Highly Elevated in Intratumoral Immune Cells in Non-small-cell Lung CancerAnders Tøndell, Sissel Gyrid Freim Wahl, Anne-Marit Sponaas, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 17, 2003
[A new nail to the coffin of the medical profession's academic affiliation]Magne Børset
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 16, 2019
Tumour-agnostic drugs and future cancer treatmentMagne Børset
Cancer Letters|December 8, 2020
Protein tyrosine phosphatases in multiple myelomaPegah Abdollahi, Maja Köhn, Magne Børset
Current Opinion in Clinical Nutrition and Metabolic Care|November 2, 2021
Phosphatases of regenerating liver are key regulators of metabolism in cancer cells - role of Serine/Glycine metabolismPegah Abdollahi, Esten N Vandsemb, Magne Børset
Blood Reviews|December 8, 2019
Why do myeloma patients have bone disease? A historical perspectiveMagne Børset, Anders Sundan, Anders Waage, et al.
The American Journal of Case Reports|February 17, 2018
Raised Serum Levels of Syndecan-1 (CD138), in a Case of Acute Idiopathic Systemic Capillary Leak Syndrome (SCLS) (Clarkson's Disease)Ole Wilhelm Bøe, Kjell Sveen, Magne Børset, et al.
The Journal of Biological Chemistry|February 5, 2003
Heparan sulfate regulates targeting of syndecan-1 to a functional domain on the cell surfaceYang Yang, Magne Børset, J Kevin Langford, et al.
Medical Oncology (Northwood, London, England)|February 17, 2007
Bone disease in multiple myelomaØyvind Hjertner, Therese Standal, Magne Børset, et al.
Mediators of Inflammation|June 3, 2014
Bronchoalveolar lavage fluid IFN-γ+ Th17 cells and regulatory T cells in pulmonary sarcoidosisAnders Tøndell, Torolf Moen, Magne Børset, et al.
Translational Oncology|November 17, 2019
Ectonucleotidase CD39 and Checkpoint Signalling Receptor Programmed Death 1 are Highly Elevated in Intratumoral Immune Cells in Non-small-cell Lung CancerAnders Tøndell, Sissel Gyrid Freim Wahl, Anne-Marit Sponaas, et al.
Pageof 6